Stock Events

Stock Events

FSD Pharma 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-2.55
-1.82
-1.09
-0.36
Expected EPS
-0.36034874464512
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-22.89MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0K9.MU. It's not an investment recommendation.
Amazon
13
AMZN
NVIDIA
13
NVDA
Microsoft
12
MSFT
AMD
12
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.03B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap545.68M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same market as FSD Pharma.
Canopy Growth
CGC
Mkt Cap435.5M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with FSD Pharma in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap167.86M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, competing in the same industry as FSD Pharma.
Green Thumb Industries
GTBIF
Mkt Cap1.56B
Green Thumb Industries is involved in the cultivation, sale, and distribution of cannabis products, making it a competitor in the cannabis industry alongside FSD Pharma.

About

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.
Show more...
CEO
ISIN
CA35954B2066

Listings

F
DE
0K91.F
STU
DE
0K91.STU
MU
DE
0K9.MU
CN
CA
QNTM.CN

0 Comments

Share your thoughts

FAQ

What is FSD Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange FSD Pharma stocks are traded under the ticker 0K9.MU.
When is the next FSD Pharma earnings date?▼
FSD Pharma is going to release the next earnings report on August 06, 2026.
What were FSD Pharma earnings last quarter?▼
0K9.MU earnings for the last quarter are -2.55 EUR per share, whereas the estimation was -0.42 EUR resulting in a -511.66% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is FSD Pharma revenue for the last year?▼
FSD Pharma revenue for the last year amounts to 0 EUR.
What is FSD Pharma net income for the last year?▼
0K9.MU net income for the last year is -22.89M EUR.
In which sector is FSD Pharma located?▼
FSD Pharma operates in the Other sector.
When did FSD Pharma complete a stock split?▼
FSD Pharma has not had any recent stock splits.